Search company, investor...

Total Raised

$3.8M

Investors Count

7

Deal Terms

2

Funding, Valuation & Revenue

8 Fundings

Bioptigen has raised $3.8M over 8 rounds.

Bioptigen's latest funding round was a Acquired for on June 2, 2015.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/2/2015

Acquired

$99M

0

FY undefined

1

9/1/2014

Convertible Note

$99M

0

FY undefined

0

3/3/2011

Unattributed VC

$99M

$99M

0

FY undefined

0

1/9/2008

Angel - II

$99M

0

FY undefined

0

9/21/2007

Angel

$99M

$99M

0

FY undefined

0

Date

6/2/2015

9/1/2014

3/3/2011

1/9/2008

9/21/2007

Round

Acquired

Convertible Note

Unattributed VC

Angel - II

Angel

Amount

$99M

$99M

Investors

Valuation

$99M

$99M

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

0

0

0

0

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Bioptigen Deal Terms

2 Deal Terms

Bioptigen's deal structure is available for 2 funding rounds, including their Series B from September 06, 2007.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

$99M

Post-Money Valuation

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

Bioptigen Investors

7 Investors

Bioptigen has 7 investors. Leica Microsystems invested in Bioptigen's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/2/2015

6/2/2015

1
Acquired

Corporation

Germany

00/00/0000

00/00/0000

BlueTree Allied Angels

Subscribe to see more

Angel Investor (Group)

Pennsylvania

00/00/0000

00/00/0000

Piedmont Angel Network

Subscribe to see more

Subscribe to see more

Angel Investor (Group)

North Carolina

00/00/0000

00/00/0000

Jefferson Corner Group

Subscribe to see more

Angel Investor (Group)

Virginia

00/00/0000

00/00/0000

IMAF-Triad

Subscribe to see more

Angel Investor (Individual)

North Carolina

First funding

6/2/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/2/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

BlueTree Allied Angels

Piedmont Angel Network

Jefferson Corner Group

IMAF-Triad

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Angel Investor (Group)

Angel Investor (Group)

Angel Investor (Group)

Angel Investor (Individual)

Location

Germany

Pennsylvania

North Carolina

Virginia

North Carolina

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.